Standout Papers

Targeting HER2-Positive Breast Cancer with Trastuzumab... 1995 2026 2005 2015 1.2k
  1. Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate (2008)
    Gail D. Lewis Phillips, Guangmin Li et al. Cancer Research
  2. Bax interacts with the permeability transition pore to induce permeability transition and cytochromecrelease in isolated mitochondria (1998)
    Masashi Narita, Shigeomi Shimizu et al. Proceedings of the National Academy of Sciences
  3. Induction of apoptosis by the Bcl-2 homologue Bak (1995)
    Thomas W. Chittenden, Elizabeth A. Harrington et al. Nature

Immediate Impact

19 by Nobel laureates 38 from Science/Nature 104 standout
Sub-graph 1 of 16

Citing Papers

De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
2 intermediate papers

Works of Robert J. Lutz being referenced

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
2008 Standout
Bak BH3 Peptides Antagonize Bcl-xL Function and Induce Apoptosis through Cytochrome c-independent Activation of Caspases
1999

Author Peers

Author Last Decade Papers Cites
Robert J. Lutz 3102 2393 4202 107 8.5k
Steven J. Harper 1215 605 4488 141 8.1k
Pier Giorgio Natali 3082 1743 5216 259 11.1k
Philip E. Thorpe 2529 1385 5720 134 10.4k
Keiryn L. Bennett 1088 544 5761 118 9.3k
Bruce A. Keyt 945 2057 5076 75 9.8k
Didier Decaudin 1802 355 3592 144 6.8k
Shinichi Kitada 3170 651 7529 112 11.7k
Adriana Haimovitz‐Friedman 2332 1936 7785 103 12.2k
Aviv Gazit 3232 714 5250 99 9.6k
Mayumi Ono 3929 597 7284 212 11.9k

All Works

Loading papers...

Rankless by CCL
2026